4 November 2024 - It’s Jemma Juckes’ last throw of the dice as she awaits a decision on whether a new cancer drug will be added to the PBS. Her life depends on it.

The 34 year old has been forced to sell her business to be able to this week start the first of its kind, targeted therapy — which comes from the US at a cost of $40,000 for the first month, and $20,000 per month thereafter.

Read Daily Telegraph article